glp 1 agonist crohn's disease ADJUNCTIVE GLP-1 RECEPTOR AGONISTS IN DISEASE: REDUCED STEROID DEPENDENCE AND HOSPITALIZATIONS IN A REAL-WORLD MULTI-NETWORK COHORT GLP-1s and Crohn's Disease: Safety,

Second Opinion Physician is dedicated to helping you navigate this journey by offering telehealth services, lab testing, and tailored therapies to address histamine excess, methylation imbalances, and mood-related disorders

In the combination therapy pilot (GHK-Cu + PDRN, n = 30, 12 weeks), participants reported a mean increase in hair length of 0.8 mm and a 20% increase in follicular width as determined by trichoscopy

Metabolic health beyond weight loss Examining effects on insulin sensitivity, lipid metabolism, and cardiovascular risk markers independent of weight changes

doi: 10.1016/j.dsx.2018.03.002 94 OrskovCWettergrenAHolstJJ